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Bacterial lipoproteins are surface exposed,
anchored to themembrane byS-diacylglycerylmodi-
fication of the N-terminal cysteine thiol. They play
important roles in many essential cellular processes
and in bacterial pathogenesis. For example, Clos-
tridium difficile is a Gram-positive anaerobe that
causes severe gastrointestinal disease; however,
its lipoproteome remains poorly characterized.
Here we describe the application of metabolic
tagging with alkyne-tagged lipid analogs, in combi-
nationwith quantitative proteomics, to profile protein
lipidation across diverse C. difficile strains and on
inactivation of specific components of the lipopro-
tein biogenesis pathway. These studies provide the
first comprehensive map of the C. difficile lipopro-
teome, demonstrate the existence of two active lipo-
protein signal peptidases, and provide insights into
lipoprotein function, implicating the lipoproteome in
transmission of this pathogen.
INTRODUCTION
Bacterial lipoproteins are surface-exposed proteins, anchored
to the cell membrane through a post-translational diacylglyceryl
modification, and participate in diverse cellular processes,
including nutrient uptake and transport, cell wall remodeling,
sporulation, signaling, adhesion, and antibiotic resistance (Chi-
malapati et al., 2012; Nielsen and Lampen, 1982; Okugawa
et al., 2012). In addition, they can activate host immune response
pathways via recognition of the diacylglyceryl motif by Toll-Like
Receptor 2 (Blanc et al., 2013).
Gram-positive lipoproteins contain an N-terminal lipobox
within their type II signal peptide sequence, which features an
invariant +1 cysteine residue (Buddelmeijer, 2015; Hutchings
et al., 2009). Following export via the general secretory pathway
(Sec), the signal peptide is retained within the membrane and a
prolipoprotein diacylglyceryl transferase (Lgt) catalyzes the co-
valent attachment of a membrane phospholipid substrate to1562 Chemistry & Biology 22, 1562–1573, November 19, 2015 ª2015the conserved cysteine, forming a thioether linkage (Sankaran
and Wu, 1994). The signal peptide is cleaved by a lipoprotein
(type II) signal peptidase (Lsp) (Hayashi et al., 1985), leaving
the mature lipoprotein anchored to the membrane via the lipid-
modified N-terminal cysteine (Figure 1). Lgt and Lsp are essential
in Gram-negative bacteria, but are dispensable in Gram-positive
bacteria studied to date, despite the essential nature of many
lipoproteins (Widdick et al., 2011).
Previous methods for studying bacterial lipoproteins rely on
radiolabeling with fatty acids, which suffers from low sensitivity
and relatively low throughput. Consequently, bioinformatics pre-
diction is commonly used but is restricted to proteins containing
awell-defined lipoboxmotif and requires experimental confirma-
tion (Rahman et al., 2008). Disruption of lipoprotein processing
by genetic inactivation of lgt (Baumgartner et al., 2007) or by in-
hibition of Lsp by the antibiotic globomycin (Reglier-Poupet
et al., 2003) have enabled identification of a small number of lipo-
proteins, but these approaches lack general applicability. In
contrast, metabolic chemical tagging with alkyne-tagged fatty
acid analogs provides a potentially global approach to study
the lipoproteome, as demonstrated in proof of principle studies
in diverse species of Gram-negatives, Gram-positives, and
Mycobacteria (Rangan et al., 2010).
Metabolic tagging takes advantage of the cell’s post-transla-
tional machinery to incorporate a chemical tag specifically at
the site of modification, allowing visualization and identification
of a certain class of post-translational modification (PTM) (Tate
et al., 2015). Typically, an analog of the natural substrate
featuring a biologically unobtrusive tag (e.g. azide or alkyne) is
used. Attachment of a fluorophore through a highly selective,
so-called bio-orthogonal, reaction enables rapid and sensitive
detection of labeled proteins, while attachment of an affinity
tag allows selective and efficient enrichment of labeled proteins
for identification by tandem mass spectrometry (MS/MS)-based
proteomic analysis. This approach has been applied to the study
of a range of PTMs, including acetylation (Yang et al., 2010), myr-
istoylation (Broncel et al., 2015; Charron et al., 2009; Thinon
et al., 2014; Wright et al., 2014), palmitoylation (Charron et al.,
2009; Martin et al., 2012), cholesterylation (Ciepla et al., 2014),
and prenylation (Berry et al., 2010; Charron et al., 2013). How-
ever, metabolic tagging and MS/MS-based identification of the
lipoproteome has not previously been applied to aGram-positive
bacterium or to pathogenic bacteria.The Authors
Figure 1. Lipoprotein Biogenesis in Gram-
Positive Bacteria
(A) Prolipoprotein diacylglyceryl transferase (Lgt)
catalyzes the addition of a diacylglyceryl fatty acid
to the invariant lipobox cysteine side chain.
(B) The N-terminal type II signal peptide is cleaved
within the lipobox, leaving the conserved cysteine
as the N-terminal residue.
(C) Themature lipoprotein remains anchored to the
membrane via the lipid modification.Clostridium difficile is a Gram-positive, spore-forming,
anaerobe that causes severe gastrointestinal disease. It is highly
antibiotic resistant and is the leading cause of hospital-acquired
infection (Kuipers and Surawicz, 2008). C. difficile infection (CDI)
typically occurs following broad-spectrum antibiotic treatment,
which disrupts the natural gut microbiota and enables coloniza-
tion (Evans and Safdar, 2015). C. difficile cells produce two
toxins, TcdA and B, which are the major virulence factors (Jank
and Aktories, 2008) and lead to symptomatic infection. Spores
produced in the gastrointestinal tract of the host during infection
are shed in feces (Lawley et al., 2009), and are responsible for
persistence and recurrence of CDI due to their resistance to dis-
infectants, desiccation, and extreme temperatures (Gerding
et al., 2008). The C. difficile lipoproteome is expected to play
an important role in CDI throughmodulation of host-pathogen in-
teractions, nutrient uptake, and sporulation. For example, the
predicted lipoprotein CD630_08730 is a surface-exposed adhe-
sin anticipated to have an important role during colonization
(Kovacs-Simon et al., 2014), while expression of the putative
lipoproteins OppA and AppA indirectly inhibits sporulation, sug-
gesting that these proteins may modulate virulence by control-
ling nutrient availability (Edwards et al., 2014).
Here we report the first global study of the C. difficile lipopro-
teome using metabolic tagging and quantitative proteomic
profiling. We demonstrate experimentally the lipidation of over
50 lipoproteins in two strains and analyze the effects of mutation
of three genes essential for lipoprotein lipidation and proteolytic
processing. Furthermore, we describe a sporulation defect in
thesemutants and identify lipoproteins implicated in sporulation,
highlighting the power of this approach for lipoprotein identifica-
tion and characterization in this important human pathogen.
RESULTS
Alkyne-Tagged Myristate Is an Efficient Probe for
C. difficile Lipoproteins
We used metabolic tagging with an alkyne-tagged fatty acid
analog, in conjunction with quantitative proteomics, to create aChemistry & Biology 22, 1562–1573, Nocomprehensive profile of the lipopro-
teome of C. difficile 630 Derm. Lgt en-
zymes typically exhibit little selectivity
with respect to the lipid substrate, ac-
cepting saturated or mono-unsaturated
fatty acids of 14–20 carbons (Nakayama
et al., 2012). We therefore used a series
of alkyne-tagged fatty acid analogs of
increasing chain length (C11, C12, C13,C14, C17, and C18), synthesized following a route previously
reported by our group (Wright et al., 2014). Exponential cultures
of C. difficile 630 were treated with each probe at 25 mM, and
incorporation into lipoproteins was assessed by in-gel fluores-
cence following selective ligation to a multifunctional capture
reagent (AzTB) through copper (I)-catalyzed azide-alkyne cyclo-
addition (CuAAC) as previously described (Broncel et al., 2015).
Ligation to AzTB permits both fluorescent detection, through a
TAMRA label, and affinity enrichment of tagged proteins,
through a PEG-Biotin label. A clear preference for longer chain
lengths was observed (Figure S1A) and alkyne-tagged myristic
acid (YnMyr) (Figure 2A) was selected for investigation of optimal
feeding concentration. A dose of 10 or 25 mM YnMyr gave the
strongest labeling, while a reduction in labeling was seen at con-
centrations higher than 50 mM, possibly due to limitations of
probe solubility (Figure S1B). Pronase treatment and western
blotting using an anti-lipoteichoic acid (LTA) antibody (Cox
et al., 2013) showed that these probes are also incorporated
into LTA, an a-D-GlcNAc(1–3)-a-D-GlcNAc glycosyl-phosphate
polymer anchored to the cell membrane by a diacylglyceryl an-
chor (Reid et al., 2012). Methanol/chloroform precipitation prior
to CuAAC effectively removed LTA from the sample, enabling
affinity enrichment of labeled proteins on NeutrAvidin resin (Fig-
ures S1C and S1D).
As lipoproteins potentially play an important role in infection,
we compared the labeled lipoproteome of strain 630with a range
of clinical isolates of different ribotypes. A broadly similar label-
ing pattern was observed for most strains with the exception of
the evolutionarily divergent strain M120 and the ribotype 027
strain R20291 (Stabler et al., 2009), which displayed a subtly
different profile to 630 (Figure 2B).
Profiling the Lipoproteome of C. difficile 630 Derm
To support lipoproteome profiling, lists of 68 and 62 po-
tential lipoproteins from C. difficile strains 630 and R20291,
respectively, were generated using bioinformatics methods
(Table S1). Broadly conserved putative functions indicated a
degree of lipoproteome conservation across these strains,vember 19, 2015 ª2015 The Authors 1563
Figure 2. Development and Optimization of Metabolic Tagging to
Target Lipidation in C. difficile
(A) The structure of the alkyne-tagged myristic acid analog, YnMyr, in com-
parison to the natural lipid.
(B) Qualitative comparison between the lipoproteomes of C. difficile strains of
representative ribotypes, visualized by metabolic tagging with 25 mM YnMyr.
(C) Competition between 10 mM YnMyr and up to 100 mM myristic acid, as
indicated.with approximately 1.8% of the proteome predicted to be
lipidated.
As genuine protein tagging through modification with YnMyr-
containing phospholipids would be expected to be out-
competed by addition of excess myristate, we implemented
a quantitative competition analysis in order to focus our lipo-
protein profile on valid substrates for lipidation. When
C. difficile 630 Derm (a derivative of 630 amenable to genetic
manipulation (Heap et al., 2007)) was grown in the presence
of 0–100 mM myristic acid and 10 mM YnMyr, a myristate-
dependent reduction in in-gel fluorescence was observed (Fig-
ure 2C). Based on these results, reduction in biotin-NeutrAvidin
enrichment of proteins tagged with 10 mM YnMyr was quanti-
fied through triplex dimethyl labeling (Boersema et al., 2009;
Li et al., 2013) at 0, 50, and 100 mM competing myristic acid.
A total of 187 enriched proteins were quantified in all three bio-
logical replicates, and 56 proteins showed a highly significant
(multiple ANOVA; p % 0.01) reduction in enrichment on
competition with an excess of myristic acid (Table S2 and Fig-1564 Chemistry & Biology 22, 1562–1573, November 19, 2015 ª2015ure 3A). Of these, 46 (82%) were predicted to be lipoproteins
by bioinformatics analysis, distributed across a range of known
or predicted functions (Table 1 and Figure 3B). Sixty-eight
percent of the predicted lipoproteome was identified, repre-
senting excellent coverage since not all predicted lipoproteins
are expected to be expressed under a single set of experi-
mental conditions. Conversely, it is also possible that a propor-
tion of predicted lipoproteins are not, in fact, genuine
substrates for Lgt.
The majority of identified lipoproteins are solute-binding
proteins associated with ABC transporters (19), which frequently
play an important role in nutrient uptake and are known to be
lipidated in other species (Alloing et al., 1994), alongside unchar-
acterized proteins (4) or putative lipoproteins (14) of unknown
function. CD630_08730, an ABC-type transporter sugar-family
extracellular solute-binding protein, was significantly out-
competed by excess myristic acid, providing the first direct evi-
dence that this is a lipoprotein. CD630_08730 has been shown to
function as an adhesin and a C. difficile mutant is unable to
adhere to Caco-2 cells, whereas the recombinant protein binds
directly to cells (Kovacs-Simon et al., 2014), suggesting that
this and other lipoproteins may play important roles in
colonization.
We also identified the extracellular chaperones PrsA
(CD630_35000) and PrsA2 (CD630_15570) as lipoproteins;
PrsA is lipidated in Bacillus subtilis and is essential in a number
of bacterial species (Kontinen and Sarvas, 1993). These proteins
have peptidylprolyl isomerase function and form part of the Sec
secretion system, assisting in the folding of exported proteins.
Their identification is important as the secondary Sec system
in C. difficile functions as the major export pathway for the
S-Layer Proteins (SLPs), and both Sec systems are essential in
C. difficile 630 (Fagan and Fairweather, 2011). It is probable
that one or both C. difficile PrsA proteins play an essential role
in the export and folding of the SLPs.
Ten proteins (18%) not predicted to be lipidated by bioinfor-
matics analysis were identified as hits, of which four were pre-
dicted to have multiple transmembrane domains and therefore
are unlikely to be lipidated by Lgt. We hypothesize that these
proteins may show enrichment and myristate-dependent
competition due to close association with a lipoprotein or re-
sidual-tagged LTA. For example, a calcium-transporting
ABC-type transporter ATPase (CD630_16370) was identified
in our analysis, and would be expected to be in close associ-
ation with a solute-binding lipoprotein. Two proteins,
CD630_18710 and CD630_19300, have lipoboxes which, in
the case of CD630_19300, perfectly match the consensus.
CD630_18710 has a predicted signal peptide, but a poorly
conserved lipobox, while CD630_19300 has an unusually
long signal peptide sequence, neither of which were correctly
identified, highlighting the limitations of a purely bioinformatics
approach.
Profiling the Lipoproteome of C. difficile R20291
The myristate competition experiment was next applied to
C. difficile R20291, an ‘‘epidemic’’ strain associated with
poor clinical outcomes (Stabler et al., 2009) and containing
over 230 unique genes compared with strain 630. A total of
110 proteins were quantified in all three biological repeats,The Authors
Figure 3. Quantitative Proteomic Analysis of
YnMyr-Tagged Proteins inC. difficile 630 and
R20291
(A) A profile plot showing all proteins from 630Derm
which showed a significant change in enrichment
on competition (multiple ANOVA, p % 0.01), data
represent the mean of three biological replicates;
error bars are omitted for clarity.
(B) The annotated functions for the proteins repre-
sented in (A); emphasis is placed on predicted
lipoproteins.
(C) A profile plot showing all proteins from R20291
that showed a significant change in enrichment on
competition (multiple ANOVA, p % 0.01), data
represent the mean of three biological replicates;
error bars are omitted for clarity. Pyc
(CDR20291_0010), an endogenously biotinylated
protein, shows increased enrichment on competi-
tion of lipoprotein labeling.
(D) The annotated functions for the proteins repre-
sented in (C); emphasis is placed on predicted
lipoproteins. Predicted lipoproteins are colored red,
other significant proteins in blue.60 of which showed a significant reduction in enrichment
(multiple ANOVA; p% 0.01) on competition with excess myris-
tic acid (Table S2 and Figure 3C), 35 (57%) of which were
predicted to be lipoproteins by bioinformatics analysis, as
summarized in Figure 3D. The remaining 25 (43%) were not
predicted to be lipidated; 5 of these (8% of total) are homologs
of predicted lipoproteins in C. difficile 630, including the
extracellular chaperones PrsA and PrsA2 and the ABC-type
transporter solute-binding proteins SsuA and AppA. In all
cases the bioinformatics predictions failed due to incorrect
assignment of translation start codons during annotation. The
remaining 20 (33%) appear to be background proteins; this
level of background enrichment may reflect a need for further
optimization of this method for application to R20291. Overall,
this result demonstrates that lipoproteins show a high degree
of conservation, both functionally and at a primary sequence
level, between these two C. difficile strains.
Lgt Catalyzes Lipidation in C. difficile
C. difficile 630 encodes a single lgt gene (CD630_26590). In a
630 Derm lgt::erm mutant (see Supplemental Information) an
almost complete loss of metabolic tagging was observed by in-
gel fluorescence, while complementation with a plasmid
expressing lgt restored the wild-type labeling pattern (Figures
4A and 4C). The lgt mutant and wild-type strains had similar
growth rates in exponential phase as measured by optical
density (data not shown). Comparison of the lipoproteomes of
630 Derm and lgt::erm by quantitative proteomics identified a
total of 210 proteins quantified in all three repeats, of which
43 proteins showed significantly increased enrichment in
630Dermover lgt::erm (p%0.05), and41werepredicted lipopro-
teins (Tables 1 and S3; Figures 4D and 4E). All but one of the pre-
dicted lipoproteins that were significantly enriched in 630 Derm
over lgt::erm showed a significant reduction in enrichment on
competition with YnMyr and myristic acid, demonstrating un-
equivocally that these proteins are labeled by YnMyr in an Lgt-
dependent manner and are therefore genuine lipoproteins.Chemistry & BioThe usefulness of the labeling approach is demonstrated by
the identification of CD603_18710, a protein not predicted to
be lipidated, but significantly enriched through tagging in
630 Derm compared with lgt::erm. We verified lipidation by
inducible expression of a C-terminal His6-tagged protein in
both 630 Derm and lgt::erm backgrounds. On induction,
CD630_18710-His6 was highly expressed in both strains, and
tagging with YnMyr occurred in an Lgt-dependent manner
(Figure S2C). Although we have not identified the site of modifi-
cation, these multiple lines of evidence strongly suggest that
lipidation of CD630_18710 occurs via the canonical pathway
despite its non-consensus lipobox.
In other bacterial species, lgt mutants can shed lipoproteins
into the media at an increased level relative to the wild-type, a
phenotype previously used to identify lipoproteins indirectly
(Baumgartner et al., 2007; Pribyl et al., 2014). In C. difficile, an
increase in the amount of protein shedwas observed for lgt::erm,
relative to 630 Derm (Figure 5A). Western blotting revealed that
the SLPs Cwp66 and LMW-SLP were also shed at an increased
rate by lgt::erm (Figure S5A). We further identified and quantified
shed proteins by proteomic analysis, normalized to total protein
recovered; 164 proteins were quantified (Figures 5B and S5;
Table S4) and, as anticipated, 23 of 24 proteins shed into the
media at a significantly (p % 0.05) increased level by lgt::erm
relative to 630 Derm were lipoproteins (Table 1 and Figure 5C).
Only 50% of lipoproteins identified through tagging could be
detected by this untargeted method, demonstrating a further
advantage of enrichment through metabolic chemical tagging
over this traditional method for lipoprotein identification.
Two Functional Lipoprotein Signal Peptidases Operate
in C. difficile
C. difficile 630 encodes two potential lsp genes, CD630_25970
(lspA) and CD630_19030 (lspA2). The existence of two lspA
genes is highly unusual, but both are conserved across all
C. difficile strains sequenced to date. Although some other
Gram-positive bacteria encode more than one lsp gene, thelogy 22, 1562–1573, November 19, 2015 ª2015 The Authors 1565
accessory Lsp may not be functional in all cases (Kovacs-Simon
et al., 2011). The existence of two functional LspAs was investi-
gated by insertionally inactivating either lspA or lspA2 in
C. difficile 630 Derm; inactivation of either lspA or lspA2 did
not affect exponential growth rates (data not shown). The in-
gel fluorescence pattern for lspA::erm showed a number of lipo-
protein bands at higher apparent molecular weight (MW) (Fig-
ure 4A), which we hypothesize is due to the retention of the
type II signal peptide. Inactivation of lspA2, in contrast, resulted
in a general reduction in labeling intensity, but relatively few
bands shifted to a higher MW. Constitutive expression of lspA
or lspA2 in trans largely restored the wild-type pattern. These
data are consistent with LspA processing themajority of lipopro-
teins, including a number of unique substrates; in contrast,
LspA2 may not have unique substrates.
Since double knockouts have, until recently, been very chal-
lenging to produce in C. difficile, we used a globomycin, a cyclic
peptide antibiotic and a specific inhibitor of Escherichia coli LspA
(Hussain et al., 1980), to further unravel the activity and potential
functional redundancy of LspA and LspA2. 630 Derm, lspA::erm,
and lspA2::erm were grown in the presence 100 mg ml1 globo-
mycin, and the effect on lipoprotein processing was investigated
by labeling with 25 mM YnMyr. Treatment with globomycin had
no effect on bacterial growth (data not shown). On globomycin
treatment, 630 Derm displayed a remarkably similar labeling
pattern to untreated lspA::erm, while lspA::erm, which pos-
sesses only LspA2, showed no significant changes. In contrast,
lspA2::erm showed dramatic changes when treated with globo-
mycin, with a global shift to higher apparent MWs of YnMyr-
tagged lipoproteins (Figure 4B). LspA is thus strongly inhibited
by 100 mg ml1 globomycin, while LspA2 is not, a conclusion
consistent with the lower sequence homology of E. coli K12
LspA to C. difficile LspA2, compared with C. difficile LspA. Glo-
bomycin treatment results in an lspA::erm-like phenotype for the
parental strain and a doubly inactivated phenotype for
lspA2::erm, while lspA::erm is unaffected by globomycin treat-
ment. Based on these data, we hypothesize that inactivation of
both LspAs (lspA2::erm + globomycin) results in a global reten-
tion of signal peptides and a corresponding migration of labeled
lipoproteins at a higher MW that is not observed for individual
inactivation of either LspA, strongly suggesting that both LspA
and LspA2 have type II signal peptidase activity.
A quantitative lipoproteome analysis between lspA::erm,
lspA2::erm, and 630 Derm was performed; the majority of the
46 predicted lipoproteins quantified showed no significant
change in enrichment between the three strains (p% 0.01), sug-
gesting that the changes in the in-gel fluorescence band pattern
are due to retention of type II signal peptides (Figure S3 and Ta-
ble S4). An unexpected increase in shedding of proteins into the
media was also observed for lspA::erm and lspA2::erm, relative
to 630 Derm (Figures 5A and S4). A quantitative proteomic com-
parison between the proteins shed by these mutants revealed
that those shed at a significantly (p % 0.05) increased level by
the lsp mutants were not lipoproteins (Table S5).
Disrupting Lipoprotein Biogenesis Reduces the
Formation of Heat-Resistant Spores
Spo0A (CD630_12140) is a transcription factor that acts as the
master control regulator for the initiation of sporulation. When1566 Chemistry & Biology 22, 1562–1573, November 19, 2015 ª2015activated by phosphorylation Spo0AP binds directly to the
DNA upstream of its targets, activating early sporulation genes
and repressing those required for stationary phase growth (Ed-
wards and McBride, 2014). Mutants in spo0A are defective in
sporulation (Underwood et al., 2009) and unable to persist in
mice or transmit between animals (Deakin et al., 2012). Incom-
plete lipoprotein processing in C. difficile 630 Derm resulted in
a significant (p % 0.05) decrease in Spo0A level for lspA::erm
and lspA2::erm of 2.5- and 4.3-fold, respectively, and a
2.2-fold reduction for lgt::erm, which approached significance
(p % 0.06), assessed by quantitative proteomic analysis of the
global proteomes (Figure 6A; Tables S3 and S4).
The lipoprotein biogenesis mutants produced a similar num-
ber of total colony-forming units (CFUs) per milliliter of culture
after 16 hr and at all further time points. However, lgt::erm
and lspA::erm exhibited a striking delay in the production of
heat-resistant spores, and significantly fewer heat-resistant
CFUs (p % 0.05 at 48 hr; p % 0.01 thereafter) were formed
than by the parental strain, while lspA2::erm did not form
spores under these conditions (Figure 6B), a result also
confirmed by phase-contrast microscopy (Figure S6). The
lack of characteristic phase bright spores for lgt::erm,
lspA::erm, and lspA2::erm indicates a profound defect in
sporulation.
Spo0A Regulation of Lipoprotein Expression in
C. difficile 630 Derm
The observed reduction in Spo0A levels in the lgt::erm,
lspA::erm, and lspA2::erm mutant strains may in turn affect
transcription of Spo0A-regulated genes that encode lipopro-
teins. In the absence of Spo0A, a number of lipoproteins
showed changes in production or lipidation level as assessed
by in-gel fluorescence, implying regulation by Spo0A (Fig-
ure 6C). To further investigate potential effects on the lipopro-
teome, and to identify sporulation-associated lipoproteins, a
quantitative lipoproteome analysis was performed between
spo0A::erm and the parental strain, 630 Derm. Forty-six of
the 168 proteins quantified were lipoproteins, and an additional
nine previously showed significantly reduced enrichment on
competition between YnMyr and excess myristate. Four
ABC-type transporter solute-binding proteins were signifi-
cantly reduced in enrichment in spo0A::erm, relative to the
parental strain, implying positive regulation by Spo0A:
CD630_07500, ModA (both p % 0.05), SsuA and OppA (both
p % 0.01) (Figure 6D and Table S6). ssuA has an upstream
Spo0A binding sequence (0A box) and is under direct positive
regulation by Spo0A (Rosenbusch et al., 2012), while
CD630_07500, modA and oppA are more likely to be indirectly
Spo0A-regulated.
We conducted a quantitative comparison between the global
proteome of these strains (Figure S7 and Table S6) and observed
a highly significant (p % 0.005) reduction in expression of both
SsuA (5-fold) and OppA (2-fold) in the insoluble sub-proteome
of spo0A::erm, confirming that the reduction in enrichment of
SsuA and OppA was due to a reduction in protein level. In addi-
tion, our data correlate well with known phenotypes of
spo0A::erm and with previous proteomic and transcriptomic
comparisons with 630 Derm (Fimlaid et al., 2013; Pettit et al.,
2014).The Authors
Table 1. The Lipoproteome of C. difficile 630 Derm
Gene Name/Locus Tag Protein Function
Predicted
Lipoprotein
Myristic Acid Competition
(p% 0.01)
630 Derm vs lgt::erm
(p% 0.05)
lgt::erm Vs 630 Derm
Shedding (p% 0.05)
appA CD630_26720 ABC-type transport system, oligopeptide-family solute-binding
protein
+ + + +
CD630_01730 putative lipoprotein + + +
CD630_01990 putative membrane-associated nucleotidase + + +
CD630_05450 uncharacterized protein + + + +
CD630_05690 putative lipoprotein + + +
CD630_06890 putative nucleotide phosphodiesterase + + +
CD630_07470 putative lipoprotein + + + +
CD630_07500 ABC-type transport system, amino acid-family extracellular
solute-binding protein
+ + +
CD630_08730 ABC-type transport system, sugar-family extracellular
solute-binding protein
+ + + +
CD630_08760 ABC-type transport system, sugar-family extracellular
solute-binding protein
+ +
CD630_09570 putative phage lipoprotein + + +
CD630_09990 ABC-type transport system, nitrate/sulfonate/taurine extracellular
solute-binding protein
+ + + +
CD630_10800 putative lipoprotein + + +
CD630_11310 putative solute-binding lipoprotein + + + +
CD630_12320 putative lipoprotein + + +
CD630_15070 putative thioredoxin + + +
CD630_15090 putative lipoprotein + + +
CD630_15570 putative peptidylprolyl isomerase (PrsA2) + +
CD630_15890 ABC-type transport system, sugar-family extracellular
solute-binding protein
+ + +
CD630_16220 uncharacterized protein + + +
CD630_16530 lipoprotein + + + +
CD630_16870 uncharacterized protein + + +
CD630_17740 ABC-type transport system, amino acid-family extracellular
solute-binding protein
+ + +
CD630_17810 putative lipoprotein + + +
CD630_18710 putative oxidoreductase Tn1549-like,CTn5-Orf30 + +
CD630_19300 uncharacterized protein +
CD630_19790 ABC-type transport system, extracellular solute-binding protein + + + +
CD630_19920 putative lipoprotein + +
CD630_20290 uncharacterized protein + + +
CD630_20520 putative lipoprotein + + +
(Continued on next page)
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Table 1. Continued
Gene Name/Locus Tag Protein Function
Predicted
Lipoprotein
Myristic Acid Competition
(p% 0.01)
630 Derm vs lgt::erm
(p% 0.05)
lgt::erm Vs 630 Derm
Shedding (p% 0.05)
CD630_21740 ABC-type transport system, cysteine/amino acid-family
extracellular solute-binding protein
+ + + +
CD630_21770 ABC-type transport system, cysteine/amino acid-family
extracellular solute-binding protein
+ + + +
CD630_23110 ABC-type transport system, molybdenum-like extracellular
solute-binding protein
+ +
CD630_23650 ABC-type transport system, nitrate/sulfonate/taurine extracellular
solute-binding protein
+ + + +
CD630_24060 putative lipoprotein + + + +
CD630_25380 putative lipoprotein + +
CD630_25500 ABC-type transport system, sugar-family extracellular solute-
binding protein
+ + + +
CD630_27010 putative lipoprotein + + + +
CD630_27190 putative polysaccharide deacetylase + + +
CD630_27630 putative lipoprotein + + +
CD630_29990 ABC-type transport system, iron-family extracellular
solute-binding protein
+ + + +
CD630_35280 ABC-type transport system, iron-family extracellular
solute-binding protein
+ + +
CD630_36690 putative exported protein + + + +
metQ CD630_14910 ABC-type transport system, methionine-specific
substrate-binding lipoprotein
+ + +
modA CD630_08690 ABC-type transport system, molybdenum-specific extracellular
solute-binding protein
+ +
oppA CD630_08550 ABC-type transport system, oligopeptide-family extracellular
solute-binding protein
+ + + +
potD CD630_10270 ABC-type transport system, spermidine/putrescine
solute-binding protein
+ +
prsA CD630_35000 peptidylprolyl isomerase PrsA-like (EC 5.2.1.8) + + + +
rbsB CD630_03000 ABC-type transport system, ribose-specific extracellular
solute-binding protein
+ + +
ssuA CD630_14840 ABC-type transport system, alkane sulfonates-family extracellular
solute-binding protein
+ + + +
ssuA2 CD630_29890 ABC-type transport system, sulfonate-family extracellular
solute-binding protein
+ +
A summary of all verified lipoproteins from C. difficile 630 Derm, evidence for Lgt specific tagging with YnMyr is indicated (+) for the given experiments, see also Table S7.
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Figure 4. Investigating Lipoprotein Biogen-
esis in C. difficile 630 Derm by Metabolic
Tagging
(A) The effect of inactivation of lgt, lspA, and lspA2
on prolipoprotein processing, visualized by
metabolic tagging with 25 mM YnMyr. Fluorescent
bands that shift to a higher MW are indicated by
arrowheads.
(B) Globomycin treatment (+) of 630 Derm,
lspA::erm, and lspA2::erm. The effect of Lsp inhi-
bition on prolipoprotein processing was assessed
by metabolic tagging with 25 mM Myr. 630 Derm
showed an lspA::erm-like phenotype on treat-
ment, while lspA2::erm showed a global migration
of labeled lipoproteins to a higher apparent MW,
as indicated by arrowheads.
(C) Affinity enrichment of lipoproteins from 630
Derm and lgt::erm. Two equivalents of the elutant
(E) samples were loaded relative to the input ()
and supernatant (S) samples. VC, vector control.
(D) A volcano plot showing the results of a one-
sample t test (p% 0.05) comparing YnMyr-tagged
proteins enriched from 630 Derm to those from
lgt::erm (see also Figure S4), CD630_18710 is
indicated. Values represent the mean of three
biological replicates.
(E) The annotated functions for all proteins that
displayed significantly (p % 0.05) different
enrichment in (D); emphasis is placed on predicted
lipoproteins. Predicted lipoproteins are colored
red, competition significant (Figure 3B) proteins
that are not predicted to be lipidated in blue, and
other proteins in gray.Finally, two lipoproteins, the ABC-type transporter solute-
binding protein SsuA2 and CD630_19300, a highly conserved
metallo-b-lactamase, showed significantly (p% 0.05) increased
enrichment in spo0A::erm (Figure 6D). As neither gene features
an upstream 0A box, they appear to be indirectly downregulated
by Spo0A, suggesting repression during sporulation; however,
the increase in SsuA2 may be an adaption to compensate for
reduced SsuA.
DISCUSSION
Here we report the use of an alkyne-tagged analog of myristic
acid (YnMyr) to profile the lipoproteome of the Gram-positive
pathogen C. difficile. Competition between YnMyr and an
excess of the natural lipid, in conjunction with quantitative pro-
teomic analyses, generated a robust profile of the lipoproteome
for 630 Derm and R20291. This is the first description of the lip-
oproteome of a Gram-positive bacterium, providing direct
biochemical verification of lipidation for the majority of the pre-
dicted lipoproteome. YnMyr labeling was shown to occur in an
Lgt-dependent manner, further validating our results. In total,
we identified 74% of the predicted C. difficile 630 Derm
lipoproteome, and an additional two novel lipoproteins (Fig-
ure 5D; Tables 1 and S7). Alignment of the lipoboxes fromChemistry & Biology 22, 1562–1573, Nothe C. difficile 630 Derm lipop-
roteins identified in this study revealed
that the lipobox differs subtly from theconsensus, with valine or threonine equally conserved in
the 2 position and a more variable 3 position. In contrast,
leucine is conserved in the 3 position in B. subtilis, while
the 2 position is less conserved. In both species, glycine is
favored in the 1 position (Figure S2D).
The presence of two active type II signal peptidases (LspA and
LspA2) has never been reported in a Gram-positive bacterium.
Utilizing genetic and chemical inactivation of the Lsps, combined
with metabolic tagging with YnMyr and quantitative proteomic
analysis, we have demonstrated the activity of both LspA and
LspA2 in C. difficile. The lipoprotein biogenesis mutants ex-
pressed reduced levels of Spo0A and display a severe defect
in formation of heat-resistant spores, demonstrating that com-
plete processing of the lipoproteome is required for efficient
sporulation and implicating lipoproteins in persistence and
transmission of this important pathogen. A quantitative compar-
ison between the lipoproteome of the asporogenous mutant
spo0A::erm and the parental strain revealed significantly
reduced enrichment of four ABC-transport solute-binding lipo-
proteins in the spo0A::erm mutant, indicative of regulation by
Spo0A, implicating these proteins in the initiation of sporulation.
We suggest that these lipoproteins may form part of a nutrient-
sensing feedback mechanism, acting to confirm low nutrient
availability before committing to sporulation.vember 19, 2015 ª2015 The Authors 1569
Figure 5. Lipoproteins Are Shed into the
Media at an Increased Level by lgt::erm
(A) Proteins shed or secreted into the media by
630 Derm and the lipoprotein biogenesis mutants.
Samples were standardized by protein
concentration (1 mg ml1) or bacterial cell mass
(30 OD600 ml
1), see also Figure S6.
(B) A volcano plot showing the results of a one-
sample t test (p% 0.05) comparing proteins shed
into the media by 630 Derm to those shed by
lgt::erm. Values represent the mean of three bio-
logical replicates.
(C) The annotated functions for all proteins that
were shed at a significantly (p % 0.05) different
level in (B); emphasis is placed on predicted lipo-
proteins. Predicted lipoproteins are colored red,
competition significant (Figure 3B) proteins that
are not predicted to be lipidated in blue and other
proteins in gray.
(D) A Euler diagram comparing all quantitative
proteomic experiments to identify C. difficile
630 Derm lipoproteins. 74% of the predicted
lipoproteome was identified, with the majority
being found in at least two independent experi-
ments.The reduction in Spo0A levels observed in the lgt::erm,
lspA::erm, and lspA2::erm mutants indicates that the lipopro-
teins involved in this phenotype act upstream of Spo0A. We
identified a number of other lipoproteins that contain other spor-
ulation-associated domains, including a homolog of the sporula-
tion-associated B. subtilis lipoprotein Med (CD630_05690). Med
is required for the activation of KinD inB. subtilis, which initiates a
phosphorelay culminating in activation of Spo0A (Banse et al.,
2011). It is possible that the C. difficileMed homolog is required
for full activity of the transmembrane kinases CD630_14920 and
CD630_24920, which act directly on Spo0A (Underwood et al.,
2009). As Spo0AP activates its own expression, a reduction
in kinase activity would lead to reduced Spo0A expression,
providing an explanation for this observation. Interestingly, in
B. subtilis Lgt is required for germination, but not for sporulation
(Igarashi et al., 2004), revealing further differences between the
developmental pathways of these two spore-forming bacteria.
Pfam analysis of the uncharacterized lipoproteins revealed li-
poproteins containing germane domains homologous to that
found in the B. subtilis lipoprotein GerM. GerM is believed to
be involved in peptidoglycan synthesis during spore develop-
ment and is required for efficient spore formation and germina-
tion (Sammons et al., 1987; Slynn et al., 1994). The germane
domain-containing lipoproteins in C. difficile may function in
both sporulation and germination, and it is possible that the
sporulation defect observed results from a combination of
altered activity of the Med and Germane homologs. While our
data do not rule out roles for lipoproteins in germination, it is
highly likely that the lipoproteome plays an important role in
sporulation in C. difficile.
In conclusion, we have demonstrated that the combination
of chemical tagging of lipidation with quantitative proteomics
is a powerful approach for experimental exploration and1570 Chemistry & Biology 22, 1562–1573, November 19, 2015 ª2015definition of the lipoproteome in a Gram-positive human
pathogen.
SIGNIFICANCE
Gram-positive lipoproteins are anchored to the cell surface
by an N-terminal S-diacylglyceryl modification. Despite the
non-essential nature of the Gram-positive lipoprotein
biogenesis pathway, they are frequently essential for bacte-
rial survival and pathogenesis. The Gram-positive pathogen
C. difficile is a leading cause of hospital-acquired infection;
spores are the transmissible agent and are critical for its
persistence in the environment. C. difficile lipoproteins
have been found to play important roles in colonization
and transmission; however, its lipoproteome remained
poorly characterized.
Here we report the application of quantitative lipoproteo-
mics to C. difficile, providing the first system-wide compar-
ative tool to address the impact of conventional genetic and
pharmacological disruption of the lipoproteome, enabling
the unbiased confirmation or revision of lipoprotein assign-
ments from bioinformatics. The usefulness of our approach
is demonstrated in the first comprehensive map of the
C. difficile lipoproteome, including that of a virulent clinical
isolate. This approach provides further insights into lipopro-
tein biogenesis in C. difficile, demonstrating the activity of
an accessory type II signal peptidase, LspA2. This study
also provides the first evidence for the importance of lipo-
protein biogenesis in sporulation, implicating lipoproteins
in the transmission of this pathogen. We anticipate that the
experimental framework presented here will find wide appli-
cation both in C. difficile and in Gram-positive pathogens in
general.The Authors
Figure 6. Lipoprotein Biogenesis Is
Required for Sporulation in C. difficile
(A) The levels of Spo0A found in the lipoprotein
biogenesis mutants is significantly reduced rela-
tive to 630 Derm, as assessed by a quantitative
proteomic comparison between the global pro-
teomes of these strains (Tables S3 and S4). Values
are the average of three biological repeats, ±SD;
*p% 0.06, **p% 0.05.
(B) Sporulation dynamics for the lipoprotein
biogenesis pathway mutants; the asporogenous
mutant spo0A::erm was included as a negative
control. All three lipoprotein biogenesis mutants
showed a significant reduction in sporulation effi-
ciency. The zero time point was taken at the onset
of the stationary phase. Values are the average for
technical triplicates of biological duplicates (six
values), ±SD. Values of zero were artificially set to 1
to allow plotting on a log10 scale, the limit of
detection (100 CFUml1) is indicated by the dotted
line.
(C) Comparison between the metabolically tagged
lipoproteomes (25 mM YnMyr or 25 mM myristic
acid) of 630 Derm and the sporulation deficient
mutant, spo0A::erm. Fluorescent bands that
showed a noticeable change in intensity are indi-
cated.
(D) A volcano plot showing the results of a one-
sample t test (p % 0.05) comparing lipoproteins
enriched from 630 Derm to those enriched from
spo0A::erm (see also Figure S7). Values represent
the mean of three biological replicates. Predicted
lipoproteins are colored red and non-predicted
competition significant proteins (Figure 3B) are
blue.EXPERIMENTAL PROCEDURES
The synthesis of the alkyne-tagged fatty acid probes, ClosTron mutagenesis,
plasmid construction, and lists of all plasmids and primers used in this study
are described in the Supplemental Information. Globomycin and the dimethyl-
labeling reagents were purchased from Sigma Aldrich and used without further
purification. NeutrAvidin agarose beads were purchased from Invitrogen.
Bacterial Culture
All C. difficile and E. coli strains used in this study are detailed in the Supple-
mental Information. C. difficile was routinely cultured on BHIS agar composed
of 3.7%BHI (Oxoid, CM1135), 0.5% yeast extract (BDBacto, 211713), 0.1% L-
cysteine (Sigma Aldrich), 1.5% Agar (BD Bacto, 214030). Liquid cultures for
metabolic labeling were performed in TY broth composed of 3% Bacto
Tryptose (BD Bacto, 211713) and 2% yeast extract (BD Bacto, 210929). Liquid
cultures for genetic manipulation and phenotypic assays (where indicated)
were performed in BHIS broth composed of 3.7% BHI (Oxoid, CM1135),
0.5% yeast extract (BD Bacto, 210929), 0.1% L-cysteine (Sigma Aldrich). All
cultures were grown at 37C under a reducing anaerobic atmosphere
(10% CO2, 10% H2, and 80% N2).
Metabolic Tagging
Overnight cultures of C. difficile were subcultured to an optical density (OD)600
of 0.05. For competition experiments, the subculture was immediately treated
with myristic acid in DMSO to the desired concentration. Synchronously
growing subcultures were allowed to grow to early exponential phase
(OD600 z 0.3) before being treated with an alkyne-tagged fatty acid analog
in DMSO; the probe and the concentration varied between experiments,
with the final concentration of DMSO for each culture fixed at 1% (v/v).
Typically, 10 or 25 mMYnMyr was used for metabolic labeling, and the cultures
were grown to stationary phase over 6–8 hr, before cell lysis.Chemistry & BioProteomic Analysis
Peptide mixtures were separated on an Easy-Nano UHPLC (ultra-high-perfor-
mance liquid chromatography; Thermo Scientific) equipped with an Acclaim
Pepmap 100 pre-column and an EASY-Spray 50 cm 3 75 mm Pepmap C18
column (Thermo Scientific) eluting using a gradient of 2% acetonitrile, 0.1% tri-
fluoroacetic acid (TFA), to 98% acetonitrile, 0.1% TFA in water at a flow rate of
250 nl min1, over 2 hr. The nano-UHPLC was connected directly to a
Q-Exactive Quadrupole-Orbitrap mass spectrometer (Thermo Scientific) for
MS/MS analysis, via a heated EASY-Spray source (Thermo Scientific) oper-
ated at a spray voltage of 1.7 kV. The Q-Exactive was run in positive ion
mode, using data-dependent (Top 10) acquisition with an isolation window
of 3.0 m/z. Ions were fragmented by higher-energy collisional dissociation
with normalized collision energies of 25 W; the ion target value was set to
106 for MS and 105 for MS/MS.
Data Analysis
Thermo.RAW files generated by Xcalibur were processed using MaxQuant
1.3.0.5 (Cox and Mann, 2008), searching against the corresponding database
using the Andromeda search engine (Cox et al., 2011). All databases to search
against were created by extracting the complete proteome of the relevant
C. difficile strain from UniProt (630 and R20291, both 08/2013); common con-
taminants were included in the search. Methionine oxidation and N-terminal
acetylation were set as variable modifications and cysteine S-carbamidome-
thylation as a fixed modification. For dimethyl-based quantification, the multi-
plicity and labels were set depending on the experiment, allowing a maximum
of three labeled amino acids per peptide. A total of five modifications per pep-
tide, twomissed cleavages, and amaximum charge of +7 was allowed. A false
discovery rate of 0.01 for peptides, proteins, and sites was used for identifica-
tion; the minimum peptide length allowed was seven amino acids. For protein
identification, the minimum number of peptides and razor + unique pe-
ptides allowed was set to 1; both razor and unique peptides were used forlogy 22, 1562–1573, November 19, 2015 ª2015 The Authors 1571
quantification. Only proteins that were quantified in all biological replicates
were used for further analysis. Data were filtered to remove common contam-
inants, normalized to the median, and statistical testing was performed using
Perseus 1.4.0.8. Protein annotationswere imported from the UniProt and Pfam
databases, and the data were exported to Microsoft Excel 2010 for further
analysis. The mass spectrometry proteomics data have been deposited in
the ProteomeXchange Consortium (Vizcaino et al., 2014) via the PRIDE partner
repository with the dataset identifier PRIDE: PXD002426.
ACCESSION NUMBERS
The accession number for the proteomics data reported in this paper is PRIDE:
PXD002426.
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Supplemental Information includes Supplemental Experimental Procedures,
seven figures, and seven tables and can be found with this article online at
http://dx.doi.org/10.1016/j.chembiol.2015.10.006.
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